Roth/MKM Reiterates Buy Rating on Creative Medical Tech Holdings Inc. (CELZ)
Tweet Send to a Friend
Roth/MKM analyst Jonathan Aschoff reiterated a Buy rating and $30.00 price target on Creative Medical Tech Holdings Inc. (NASDAQ: CELZ).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


